Skip to Content

Tag: european oxygen market


News

In brief: CMS delays F2F rule again, Golden endorses Reverie

September 13, 2013HME News Staff

BALTIMORE - CMS had no choice but to delay—for the second time—enforcement of its face-to-face rule until sometime in 2014, say industry stakeholders. “We just haven't seen any further education,” said Kim Brummett, senior director of regulatory affairs for AAHomecare. In its Sept. 9 announcement, CMS said the delay is needed to give providers and healthcare practitioners time to establish necessary protocols to fully comply with the rule. The face-to-face requirement took...

a/r allegiance group, budesonide, european oxygen market, face to face, FMCSA, golden technologies, Maddak, medbill, Medicare, OIG


Read Full Articlered right arrow icon

Also Noted

Invacare leads growing oxygen market in Europe

September 12, 2013HME News Staff

VANCOUVER, British Columbia - Europe's 59 million Euro oxygen therapy market is expected to grow as the continent's population ages and former smokers develop lung disease, iData Research reported recently. “Among western European countries, France has the largest number of patients on long-term oxygen therapy, and the extensive use of oxygen concentrators is encouraged by some of the highest reimbursement rates in Europe,” said Kamran Zamanian, CEO of iData, in a press release. Conversely,...

AirSep, DeVilbiss, european oxygen market, ingen one, Invacare, philips respironics, SeQual


Read Full Articlered right arrow icon